Delivery Order SPE2DB22D1106-SPE2DB24FFHT0
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$76K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $27,366.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of August 1, 2024 and is not set aside for any special categories of contractors. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,485.56 fixed-price delivery order is for the supply of GARDASIL 9 vaccine syringes, a medical product used for immunization. The order has a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,616.78 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The award, which has no set-aside designation, has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to various federal agencies and healthcare programs, including the military....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,610.17 firm fixed-price contract is for the delivery of GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $24,574.24 firm fixed price contract is for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This is a $12,172.82 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 vaccine syringes. The contract has a firm fixed price and an ultimate completion date of February 27, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,074.64 firm-fixed-price contract is for the supply of 4565907464 GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of September 24, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,786.65 fixed-price delivery order is for the supply of GARDASIL 9 vaccine syringes, a preventative medical product. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,252.15, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of GARDASIL 9 syringes, a vaccine medication, with a potential value of $3,181.05. The order has a completion date of March 5, 2024 and was awarded on March 4, 2024. Amerisourcebergen Drug Corp holds an...